Product Description

Erlocip 150mg Tablet is an anticancer medicine containing active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers.

You need to inform your doctor if you use contact lenses, have an intolerance to sugars, history of eye problems, clotting disorders, or if you take medicines for clotting disorders or cholesterol. Erlocip 150mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose. 

You are advised not to smoke while being treated with Erlocip 150mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform your physician if you develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.

How to use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlocip 150 Tablet is to be taken empty stomach.

Uses

Treatment of Lung cancer

Side Effects

Serious:

• Persistent or severe diarrhea
• Pain in the eye, blurred vision
• Sudden difficulty in breathing accompanied by cough and fever
• Severe pain in your abdomen
• Liver failure

Common:

• Rash, worsened in sun-exposed areas
• Loss of appetite, decreased weight
• Infection
• Headache
• Depression
• Nausea
• Mouth irritation
• Indigestion
• Hair loss, dry skin, itching, acne, cracked skin
• Tiredness

Storage

Store below 30℃